April 02, 2025

Unequal Access Worsens Opioid Crisis for Black Patients

Despite rising opioid overdose rates among Black patients, systemic barriers and unequal access to treatment continue to hinder recovery efforts and worsen outcomes.

KFF Health News

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 27, 2025

FDA Examines Stimulant Use Trends

The FDA reviews rising adult prescription stimulant use, ongoing shortages, and efforts to ensure appropriate access and minimize nonmedical use.

Conexiant

March 24, 2025

New State Model for Psilocybin Therapy

Read about the emergence of state-regulated psychedelic mushrooms in Colorado and their potential therapeutic applications.

KFF Health News

March 20, 2025

FDA Youth E-Cigarette Ad Linked to Lower Initiation

E-cigarette initiation among U.S. youth was reduced following The Real Cost Youth E-cigarette Prevention Campaign.

Conexiant

March 13, 2025

FDA Chief Counsel Resigns Two Days In

U.S. FDA's chief counsel resigns amidst controversy surrounding her appointment and connections to mifepristone during the Biden administration.

Reuters

March 07, 2025

CDC Plans Study on Autism Causes

The CDC is launching a large-scale study on autism prevalence and potential contributing factors. Previous research has found no causal link between vaccines and autism, though diagnoses have risen due to expanded screening and diagnostic criteria.

Reuters

April 29, 2024

Record Heat Waves Propel Surge in Heat-Related Illness

2023 brought record-breaking heat waves in the United States, significantly impacting vulnerable groups. Analysis by the CDC revealed a substantial number of heat-related illness (HRI) emergency department visits, resulting in multiple public health alerts.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant